Literature DB >> 33758211

The Groningen electrocardiographic criteria for left ventricular hypertrophy: a sex-specific analysis.

M Yldau van der Ende1, Tom Hendriks1, Yordi van de Vegte1, Erik Lipsic1, Harold Snieder2, Pim van der Harst3.   

Abstract

The sensitivity of electrocardiogram (ECG) criteria to detect left ventricular hypertrophy (LVH) is low, especially in women. We determined sex-specific sensitivities of ECG-LVH criteria, and developed new criteria, using cardiovascular magnetic resonance imaging (CMR). Sensitivities of ECG-LVH criteria were determined in participants of the UK Biobank (N = 3632). LVH was defined when left ventricular mass was > 95% confidence interval (CI) according to age and sex. In a training cohort (75%, N = 2724), sex-specific ECG-LVH criteria were developed by investigating all possible sums of QRS-amplitudes in all 12 leads, and selecting the sum with the highest pseudo-R2 and area under the curve to detect LVH. Performance was assessed in a validation cohort (25%, N = 908), and association with blood pressure change was investigated in an independent cohort. Sensitivities of ECG-LVH criteria were low, especially in women. Newly developed Groningen-LVH criterion for women (QV2 + RI + RV5 + RV6 + SV2 + SV4 + SV5 + SV6) outperformed all ECG-LVH criteria with a sensitivity of 42% (95% CI 35-49%). In men, newly developed criterion ((RI + RV5 + SII + SV2 + SV6) × QRS duration) was equally sensitive as 12-lead sum with a sensitivity of 44% (95% CI 37-51%) and outperformed the other criteria. In an independent cohort, the Groningen-LVH criteria were strongest associated with change in systolic blood pressure. Our proposed CMR sex-specific Groningen-LVH criteria improve the sensitivity to detect LVH, especially in women. Further validation and its association with clinical outcomes is warranted.

Entities:  

Mesh:

Year:  2021        PMID: 33758211      PMCID: PMC7988153          DOI: 10.1038/s41598-021-83137-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  26 in total

1.  Population-based values and abnormalities of the electrocardiogram in the general Dutch population: The LifeLines Cohort Study.

Authors:  M Yldau van der Ende; Joylene E Siland; Harold Snieder; Pim van der Harst; Michiel Rienstra
Journal:  Clin Cardiol       Date:  2017-06-12       Impact factor: 2.882

2.  Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement.

Authors:  Fabio Angeli; Paolo Verdecchia; Enrica Angeli; Fabrizio Poeta; Mariagrazia Sardone; Maurizio Bentivoglio; Lucio Prosciutti; Maurizio Cocchieri; Liliana Zollino; Gianni Bellomo; Francesco Rondoni; Oriana Garognoli; Salvatore Lenti; Carlo Frigerio; Roberto Gattobigio; Guglielmo Benemio; Bruno Biscottini; Rosita Panciarola; Massimo Buccolieri; Rita Liberati; Mario Trottini; Franco Cipollini; Fabio Gemelli; Giuseppe Schillaci; Carlo Porcellati
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2006-11       Impact factor: 2.160

3.  The LifeLines Cohort Study: Prevalence and treatment of cardiovascular disease and risk factors.

Authors:  M Yldau van der Ende; Minke H T Hartman; Yanick Hagemeijer; Laura M G Meems; Hendrik Sierd de Vries; Ronald P Stolk; Rudolf A de Boer; Anna Sijtsma; Peter van der Meer; Michiel Rienstra; Pim van der Harst
Journal:  Int J Cardiol       Date:  2016-11-11       Impact factor: 4.164

4.  Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.

Authors:  Riitta L Antikainen; Ruth Peters; Nigel S Beckett; Robert H Fagard; Ji-Guang Wang; Chakravarthi Rajkumar; Christopher J Bulpitt
Journal:  J Hypertens       Date:  2016-11       Impact factor: 4.844

5.  Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.

Authors:  Kristian Wachtell; Jonathan N Bella; Jens Rokkedal; Vittorio Palmieri; Vasilios Papademetriou; Björn Dahlöf; Tapio Aalto; Eva Gerdts; Richard B Devereux
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

6.  ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population.

Authors:  Kimmo Porthan; Teemu J Niiranen; Juha Varis; Ilkka Kantola; Hannu Karanko; Mika Kähönen; Markku S Nieminen; Veikko Salomaa; Heikki V Huikuri; Antti M Jula
Journal:  J Hypertens       Date:  2015-06       Impact factor: 4.844

7.  Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product.

Authors:  T J Molloy; P M Okin; R B Devereux; P Kligfield
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

8.  Gender differences and the electrocardiogram in left ventricular hypertrophy.

Authors:  P M Okin; M J Roman; R B Devereux; P Kligfield
Journal:  Hypertension       Date:  1995-02       Impact factor: 10.190

9.  Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy.

Authors:  A L Dollar; W C Roberts
Journal:  Am J Med       Date:  1989-10       Impact factor: 4.965

10.  Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort.

Authors:  Steffen E Petersen; Nay Aung; Mihir M Sanghvi; Filip Zemrak; Kenneth Fung; Jose Miguel Paiva; Jane M Francis; Mohammed Y Khanji; Elena Lukaschuk; Aaron M Lee; Valentina Carapella; Young Jin Kim; Paul Leeson; Stefan K Piechnik; Stefan Neubauer
Journal:  J Cardiovasc Magn Reson       Date:  2017-02-03       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.